Who invested in Pipeline Therapeutics?
Pipeline Therapeutics's investors include Sectoral Asset Management, Versant Ventures, Hadean Ventures, RBV Capital and Cleva Pharma Capital. Sectoral Asset Management led its latest round.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2019, from 1 source
Reported by Hadean Ventures
Pipeline Therapeutics's investors include Sectoral Asset Management, Versant Ventures, Hadean Ventures, RBV Capital and Cleva Pharma Capital. Sectoral Asset Management led its latest round.
Pipeline Therapeutics has raised $30M across 1 round since 2019.
Pipeline Therapeutics's most recent round was a Series B of $30M in Dec 2019, led by Sectoral Asset Management.
Its most recent round, $30M in Dec 2019, is also its largest on record.
Pipeline Therapeutics's first round on record, in Dec 2019, was backed by Sectoral Asset Management, Versant Ventures and Hadean Ventures and 2 others.
Pipeline Therapeutics's latest named round is a Series B, in Dec 2019.
Pipeline Therapeutics is based in the United States.
Sectoral Asset Management led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.